PARK AVENUE SECURITIES LLC
Broker-DealerPosition in LH — Labcorp Holdings Inc.
CIK 1071640
NEW YORK, NY
Position in LH
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,450,120
+$141,951 QoQ
Shares Held
5,179
+5.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#405
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $23,609,326 across 14 Diagnostics & Research names. LH ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,955 | $5,993,758 | |
| 2 | DHR |
Danaher Corp /De/
|
15,367 | $2,927,106 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
12,885 | $2,489,639 | |
| 4 | NTRA |
Natera, Inc.
|
9,084 | $2,465,851 | |
| 5 | DGX |
Quest Diagnostics Inc
|
9,611 | $2,037,051 | |
| 6 | A |
Agilent Technologies, Inc.
|
11,890 | $1,579,348 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
5,179 | $1,450,120 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
2,395 | $1,268,368 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,450,120 | 5,179 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,308,169 | 4,903 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,215,011 | 4,843 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $1,529,742 | 5,329 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,534,108 | 5,844 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,662,694 | 7,144 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,496,313 | 6,525 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,188,913 | 5,320 | Shares | Sole | 2024-10-03 | |
| No filing history on record for this holder in this stock. | ||||||